Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

被引:0
|
作者
Orestes Santos-Morales
Alina Díaz-Machado
Daise Jiménez-Rodríguez
Yaisel Pomares-Iturralde
Tatiana Festary-Casanovas
Carlos A. González-Delgado
Sonia Pérez-Rodríguez
Eulalia Alfonso-Muñoz
Carmen Viada-González
Patricia Piedra-Sierra
Idrian García-García
Daniel Amaro-González
Julio César García-Rodríguez
Iliana Sosa-Testé
Alicia Lagarto-Parra
Laura Barrero-Viera
Marlene David-Baldo
Maura Tamayo-Rodríguez
Ivonne Rivero-Vázquez
Gricel González-Gamiz
Alis Martín-Trujillo
Yasmila Rodríguez-Fernández
Ana Alfa Ledo-de la Luz
Maylén Álvarez-Delgado
Ivón Howland-Álvarez
Yolanda Cruz-Gómez
机构
[1] NeuroEPO Research and Development Group,National Center for Toxicology
[2] Center of Molecular Immunology,undefined
[3] “Carlos J. Finlay” University Hospital,undefined
[4] Clinical Trials Group,undefined
[5] Research Direction,undefined
[6] Center for Drug Research and Development (CIDEM),undefined
来源
BMC Neurology | / 17卷
关键词
Non-hematopoietic recombinant erythropoietin; NeuroEPO; Stroke; Neurodegenerative diseases; Healthy volunteers; Safety; Hematopoietic activity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Safety assessment of turmeric-boswellia-sesame formulation in healthy adult volunteers: An open-label prospective study
    Kim, Se-Kwon
    Jayachandran, Venkatesan
    Vo, Thanh Sang
    Wijesekara, Isuru
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2025,
  • [32] Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study
    Chen, Rui
    Chen, Xia
    Wang, Hongyun
    Zhong, Wen
    Oh, Eun Sil
    Park, Min Soo
    Kumagai, Yuji
    Zhou, Li
    Nagahama, Fumiko
    Hu, Pei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (01) : 24 - 31
  • [33] Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study
    Abhyankar, Dhiraj
    Shedage, Ashish
    Gole, Milind
    Raut, Preeti
    THERAPEUTIC DELIVERY, 2016, 7 (08) : 545 - 551
  • [34] Pharmacokinetics and tolerability of cinitapride in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study
    Zhang, Xiong
    Wang, Ying
    Cheng, Junlin
    Hu, Yunfang
    Liu, Jianghui
    Chen, Jing
    Yang, Xingye
    Fan, Hongwei
    XENOBIOTICA, 2019, 49 (03) : 313 - 321
  • [35] Pharmacokinetic Properties and Safety Profile of Histamine Dihydrochloride Injection in Chinese Healthy Volunteers: A Phase I, Single-center, Open-label, Randomized Study
    Li, Jiapeng
    Huang, Xiaojun
    Wang, Qian
    Jing, Shan
    Jiang, Hao
    Wei, Zhongna
    Zang, Yannan
    Liu, Yang
    Zhao, Libo
    Fang, Yi
    Feng, Wanyu
    CLINICAL THERAPEUTICS, 2015, 37 (10) : 2352 - 2364
  • [36] Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study
    Li, Huafang
    Li, Ting
    Li, Yan
    Shen, Yifeng
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2013, 11 (01) : 28 - 33
  • [37] Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study
    Mushtaq, Mehwish
    Fatima, Kshaf
    Ahmad, Aneeqa
    Ibrahim, Osama Mohamed
    Faheem, Muhammad
    Shah, Yasar
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [38] Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers
    Lodise, Thomas P.
    O'Donnell, J. Nicholas
    Raja, Shruti
    Guptill, Jeffrey T.
    Zaharoff, Smitha
    Schwager, Nyssa
    Fowler, Vance G., Jr.
    Beresnev, Tatiana
    Wall, Alison
    Wiegand, Katherine
    Chrisos, Elisavet Serti
    Balevic, Stephen
    Chambers, Henry F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [39] Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers
    Grasela, DM
    LaCreta, FP
    Kollia, GD
    Randall, DM
    Uderman, HD
    PHARMACOTHERAPY, 2000, 20 (03): : 330 - 335
  • [40] Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers - A phase I open-label study
    Lasseter, KC
    Dilzer, SC
    Vargas, R
    Waldman, S
    Noveck, RJ
    CLINICAL PHARMACOKINETICS, 2004, 43 (02) : 121 - 129